A statistical perspective on the ICH Q2A and Q2B guidelines for validation of analytical methods

BioPharm International

Volumn 19, Issue 12, 2006, Pages 28-36

  Walfish, Steven ^a,b  

^a Statistical Outsourcing Services   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANALYTICAL RESEARCH; ARTICLE; ASSAY; DATA ANALYSIS; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 33846221100     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Krause SO. Analytical method validation for biopharmaceuticals: a practical guide. Guide to Validation. Supp to BioPharm Int. 2005 Mar; 26-34.
2. Kanarek AD. Method validation guidelines. Guide to Bioanalytical Advances. Supp to BioPharm Int. 2005 Sep; 28-33.
3. US Food and Drug Administration. Guidance for industry: Q2B validation of analytical procedures: methodology. Rockville, MD: Nov 1996.
4. US FDA. Guideline for industry: text on validation of analytical procedures: ICH Q2A. Rockville, MD: Mar 1995.
5. Rodbard D. Statistical estimation of the minimal detectable concentration (sensitivity) for radioligand assays. Analytic Biochem. 1978;90:1-12.
6. Hauck WW, Capen RC, Callahan JD, De Muth JE, Hsu H, Lansky D, et al. Assessing parallelism prior to determining relative potency. PDA J Pharma Sci Technol. 2005;59(2):127-37.
7. Daniel C, Wood FS. Fitting equations to data. 2nd ed. New York: Wiley & Sons; 1980.
8. Dixon WJ, Massey FJ. Introduction to statistical analysis. New York: McGraw-Hill; 1969.
9. Box GEP, Hunter WG, Hunter JS. Statistics for experimenters. New York: Wiley & Sons; 1978.